NeurologyLive® Mind Moments®
127 - 114: Phase 3 PHOENIX Study, AMX0035, and Amylyx's Future Drug Development
127 - 114: Phase 3 PHOENIX Study, AMX0035, and Amylyx's Future Drug Development
Mind Moments®, a podcast from NeurologyLive® (https://www.neurologylive.com/) , brings you exclusive interviews with experts in neurologic disorders. Listen in to hear the latest clinical and research updates from major medical conferences, as well as insights on the management of complex disorders, including epilepsy, migraine, Alzheimer disease, stroke, multiple sclerosis, Parkinson disease, and more. For more expert insight into neurology, visit NeurologyLive.com (https://www.neurologylive.com/) .
More episodes
-
127 - 114: Phase 3 PHOENIX Study, AMX0035, and Amylyx's Future Drug DevelopmentFri, 03 May 2024
-
126 - Special Episode: FDA Approval of Diazepam Buccal Film for Pediatric SeizuresWed, 01 May 2024
-
125 - 113: Lessons Learned in Alzheimer Drug DevelopmentFri, 19 Apr 2024
-
124 - 112: Exploring Dimethyl Fumarate to Treat Friedreich AtaxiaFri, 05 Apr 2024
-
123 - Special Episode: FDA Approval of Givinostat for Duchenne Muscular DystrophyFri, 29 Mar 2024
Tunjuk lebih episod
5
Lebih audio siar pendidikan
Cari stesen radio anda